Current:Home > MarketsTornado-damaged Pfizer plant in North Carolina restarts production -WealthX
Tornado-damaged Pfizer plant in North Carolina restarts production
View
Date:2025-04-16 01:36:28
ROCKY MOUNT, N.C. (AP) — A major Pfizer pharmaceutical plant in North Carolina that makes critical supplies for U.S. hospitals has restarted production about 10 weeks after it was heavily damaged by a tornado, the company announced Monday.
Getting a majority of manufacturing lines at the Rocky Mount facility back up and running is a “proud achievement,” Pfizer said in a statement. Full production across the facility’s three manufacturing sites is expected by the end of the year.
Parts of the massive plant’s roofs were ripped open and pallets of medicine tossed around when the tornado touched down on July 19. But most of the damage was to a storage facility for raw materials, packaging supplies and finished medicines, rather than its medicine production areas, Pfizer said. No employees were hurt.
The plant produces anesthesia and other drugs as well as nearly one-fourth of the sterile injectable medications Pfizer supplies to U.S. hospitals, the company said.
Thirteen medicines were prioritized based on patient need and inventory levels, and are now back in production on the lines that have restarted, Pfizer said. The medicines are expected to ship to distribution centers in the fourth quarter of this year. Although manufacturing has resumed, the company said some medicines may not be back in full supply until next year.
veryGood! (19757)
Related
- 2025 'Doomsday Clock': This is how close we are to self
- In 'The Last of Us,' there's a fungus among us
- 'Black on Black' celebrates Black culture while exploring history and racial tension
- From elected official to 'Sweatshop Overlord,' this performer takes on unlikely roles
- Military service academies see drop in reported sexual assaults after alarming surge
- How should we be 'Living'? Kurosawa and Ishiguro tackle the question, 70 years apart
- 5 takeaways from the Oscar nominations
- Doug Emhoff has made antisemitism his issue, but says it's everyone's job to fight it
- Scoot flight from Singapore to Wuhan turns back after 'technical issue' detected
- 'All the Beauty in the World' conveys Met guard's profound appreciation for art
Ranking
- Apple iOS 18.2: What to know about top features, including Genmoji, AI updates
- 30 years after the siege, 'Waco' examines what led to the catastrophe
- 'Magic Mike's Last Dance': I see London, I see pants
- Fans said the future of 'Dungeons & Dragons' was at risk. So they went to battle
- The Grammy nominee you need to hear: Esperanza Spalding
- With fake paperwork and a roguish attitude, he made the San Francisco Bay his gallery
- '80 for Brady' assembles screen legends to celebrate [checks notes] Tom Brady
- 30 years after the siege, 'Waco' examines what led to the catastrophe
Recommendation
Why members of two of EPA's influential science advisory committees were let go
'Sam,' the latest novel from Allegra Goodman, is small, but not simple
2022 Books We Love: Nonfiction
Police are 'shielded' from repercussions of their abuse. A law professor examines why
Macy's says employee who allegedly hid $150 million in expenses had no major 'impact'
Encore: The lasting legacy of Bob Ross
He watched the Koons 'balloon dog' fall and shatter ... and wants to buy the remains
Encore: The lasting legacy of Bob Ross